サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1420914

ナノ粒子受託製造市場：世界の業界分析、規模、シェア、成長、動向、予測、2023～2031年

Nanoparticle Contract Manufacturing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 190 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.70円
ナノ粒子受託製造市場：世界の業界分析、規模、シェア、成長、動向、予測、2023～2031年
出版日: 2023年12月01日
発行: Transparency Market Research
ページ情報: 英文 190 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ナノ粒子受託製造市場- レポートの範囲

世界のナノ粒子受託製造市場に関するTMRのレポートは、過去と現在の成長動向、および2023年から2031年の予測期間中に市場の指標の貴重な洞察を得る機会を研究しています。当レポートは、2023年を基準年、2031年を予測年とし、2017年から2031年の期間における世界市場の収益を提供します。また、2023年から2031年までの複合年間成長率（CAGR %）も提供します。

このレポートは広範な調査を経て作成されました。1次調査では、調査活動の大部分が行われ、アナリストが主要なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施しました。2次調査には、ナノ粒子受託製造市場を理解するために、主要企業の製品文献、年次報告書、プレスリリース、および関連文書の参照が含まれます。

市場スナップショット
2023年の市場価値 22億米ドル
2031年の市場価値 43億米ドル
CAGR 7.7%

このレポートは、世界のナノ粒子受託製造市場の競合情勢を詳しく掘り下げています。世界のナノ粒子受託製造市場で活動する主要企業が特定され、それぞれの企業がさまざまな属性の観点からプロファイルされています。会社概要、財務状況、最近の動向、 SWOTは、このレポートで紹介されている世界のナノ粒子受託製造市場のプレーヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • 概要
  • 市場力学
  • 世界市場価値の分析と予測、2023～2031年

第5章 重要な洞察

  • 主要な業界イベント
  • 技術の進歩
  • COVID-19感染症パンデミックによる業界への影響（バリューチェーンと短期・中期・長期的な影響）

第6章 世界市場分析：ナノ粒子タイプ別

  • イントロダクション
  • 世界市場シェア分析：ナノ粒子タイプ別
  • 世界市場の魅力分析：ナノ粒子タイプ別
  • 世界市場分析：ナノ粒子タイプ別
  • 世界市場予測：ナノ粒子タイプ別
    • 金属ナノ粒子
    • 脂質ナノ粒子
    • その他

第7章 世界市場分析：製造規模別

  • イントロダクション
  • 世界市場シェア分析：製造規模別
  • 世界市場の魅力分析：製造規模別
  • 世界市場分析：製造規模別
  • 世界市場予測：製造規模別
    • 商業
    • 臨床
    • 前臨床

第8章 世界市場分析：用途別

  • イントロダクション
  • 世界市場シェア分析：用途別
  • 世界市場の魅力分析：用途別
  • 世界市場分析：用途別
  • 世界市場予測：用途別
    • 治療
    • 診断
    • ワクチン

第9章 世界市場分析：エンドユーザー別

  • イントロダクション
  • 世界市場シェア分析：エンドユーザー別
  • 世界市場の魅力分析：エンドユーザー別
  • 世界市場分析：エンドユーザー別
  • 世界市場予測：エンドユーザー別
    • 製薬会社
    • バイオテクノロジー企業

第10章 世界市場分析：地域別

  • イントロダクション
  • 世界市場シェア分析：地域別
  • 世界市場の魅力分析：地域別
  • 世界市場予測：地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ

第11章 北米市場分析

  • 主要な洞察：北米市場
  • 北米市場概要
  • 北米市場予測：国別
    • 米国
    • カナダ
  • 北米市場シェアと魅力度分析：ナノ粒子タイプ別
  • 北米市場予測：ナノ粒子タイプ別
    • 金属ナノ粒子
    • 脂質ナノ粒子
    • その他
  • 北米市場シェアと魅力度分析：製造規模別
  • 北米市場予測：製造規模別
    • 商業
    • 臨床
    • 前臨床
  • 北米市場シェアと魅力分析：用途別
  • 北米市場予測：用途別
    • 治療
    • 診断
    • ワクチン
  • 北米市場シェアと魅力度分析：エンドユーザー別
  • 北米市場予測：エンドユーザー別
    • 製薬会社
    • バイオテクノロジー企業

第12章 欧州市場分析

  • 主要な洞察：欧州市場
  • 欧州市場概要
  • 欧州市場予測：国別
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 欧州市場シェアと魅力分析：ナノ粒子タイプ別
  • 欧州市場予測：ナノ粒子タイプ別
    • 金属ナノ粒子
    • 脂質ナノ粒子
    • その他
  • 欧州市場シェアと魅力分析：製造規模別
  • 欧州市場予測：製造規模別
    • 商業
    • 臨床
    • 前臨床
  • 欧州市場シェアと魅力分析：用途別
  • 欧州市場予測：用途別
    • 治療
    • 診断
    • ワクチン
  • 欧州市場シェアと魅力分析：エンドユーザー別
  • 欧州市場予測：エンドユーザー別
    • 製薬会社
    • バイオテクノロジー企業

第13章 アジア太平洋市場分析

  • 主要な洞察：アジア太平洋市場
  • アジア太平洋市場概要
  • アジア太平洋市場予測：国別
    • 中国
    • 日本
    • インド
    • オーストラリアとニュージーランド
    • その他アジア太平洋地域
  • アジア太平洋地域の市場シェアと魅力分析、
    • ナノ粒子タイプ別
  • アジア太平洋市場予測：ナノ粒子タイプ別
    • 金属ナノ粒子
    • 脂質ナノ粒子
    • その他
  • アジア太平洋地域の市場シェアと魅力度分析：製造規模別
  • アジア太平洋市場予測：製造規模別
    • 商業
    • 臨床
    • 前臨床
  • アジア太平洋地域の市場シェアと魅力分析：用途別
  • アジア太平洋市場予測：用途別
    • 治療
    • 診断
    • ワクチン
  • アジア太平洋地域の市場シェアと魅力度分析：エンドユーザー別
  • アジア太平洋市場予測：エンドユーザー別
    • 製薬会社
    • バイオテクノロジー企業

第14章 ラテンアメリカ市場分析

  • 重要な洞察：ラテンアメリカ市場
  • ラテンアメリカ市場概要
  • ラテンアメリカ市場予測：国別
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ
  • ラテンアメリカ市場シェアと魅力分析：ナノ粒子タイプ別
  • ラテンアメリカ市場予測：ナノ粒子タイプ別
    • 金属ナノ粒子
    • 脂質ナノ粒子
    • その他
  • ラテンアメリカ市場シェアと魅力度分析：製造規模別
  • ラテンアメリカ市場予測：製造規模別
    • 商業
    • 臨床
    • 前臨床
  • ラテンアメリカ市場シェアとアプリケーション別の魅力分析
  • ラテンアメリカ市場予測：用途別
    • 治療
    • 診断
    • ワクチン
  • ラテンアメリカ市場シェアと魅力分析：エンドユーザー別
  • ラテンアメリカ市場予測：エンドユーザー別
    • 製薬会社
    • バイオテクノロジー企業

第15章 中東およびアフリカ市場分析

  • 主要な洞察：中東およびアフリカ市場
  • 中東およびアフリカ市場概要
  • 中東・アフリカ市場予測：国別
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ
  • 中東・アフリカの市場シェアと魅力度分析：ナノ粒子タイプ別
  • 中東・アフリカ市場予測：ナノ粒子タイプ別
    • 金属ナノ粒子
    • 脂質ナノ粒子
    • その他
  • 中東・アフリカの市場シェアと魅力度分析：製造規模別
  • 中東・アフリカ市場予測：製造規模別
    • 商業
    • 臨床
    • 前臨床
  • 中東・アフリカの市場シェアと魅力分析：用途別
  • 中東・アフリカ市場予測：用途別
    • 治療
    • 診断
    • ワクチン
  • 中東・アフリカの市場シェアと魅力度分析：エンドユーザー別
  • 中東・アフリカ市場予測：エンドユーザー別
    • 製薬会社
    • バイオテクノロジー企業

第16章 競合情勢

  • 市場プレーヤー-競合マトリックス（企業の階層および規模別）
  • 市場シェア分析：企業別（2022年）
  • 企業プロファイル
    • AstraZeneca
    • Evonik Industries AG
    • Ascendia Pharmaceuticals
    • Axolabs（LGC Limited）
    • AVANSA Technology &Services
    • Ardena Holding NV.
    • Cytodiagnostics, Inc.
    • American Elements
    • Encapsula NanoSciences LLC
    • Fortis Life Sciences
    • Hongwu International Group Ltd.
    • MyBiotech
    • Nanochemazone
図表

List of Tables

  • Table 01: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Type of Nanoparticles, 2017-2031
  • Table 02: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Manufacturing Scale, 2017-2031
  • Table 03: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 04: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 05: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: North America Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 07: North America Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Type of Nanoparticle, 2017-2031
  • Table 08: North America Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Manufacturing Scale, 2017-2031
  • Table 09: North America Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 10: North America Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 11: Europe Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 12: Europe Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Type of Nanoparticle, 2017-2031
  • Table 13: Europe Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Manufacturing Scale, 2017-2031
  • Table 14: Europe Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 15: Europe Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 16: Asia Pacific Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 17: Asia Pacific Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Type of Nanoparticle, 2017-2031
  • Table 18: Asia Pacific Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Manufacturing Scale, 2017-2031
  • Table 19: Asia Pacific Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 20: Asia Pacific Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Latin America Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 22: Latin America Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Type of Nanoparticle, 2017-2031
  • Table 23: Latin America Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Manufacturing Scale, 2017-2031
  • Table 24: Latin America Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 25: Latin America Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 26: Middle East & Africa Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 27: Middle East & Africa Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Type of Nanoparticle, 2017-2031
  • Table 28: Middle East & Africa Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Manufacturing Scale, 2017-2031
  • Table 29: Middle East & Africa Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 30: Middle East & Africa Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Nanoparticle Contract Manufacturing Market Size, by Type of Nanoparticles, 2022
  • Figure 02: Nanoparticle Contract Manufacturing Market share (%), by Type of Nanoparticles, 2022
  • Figure 03: Global Nanoparticle Contract Manufacturing Market Size, by Manufacturing Scale, 2022
  • Figure 04: Nanoparticle Contract Manufacturing Market share (%), by Manufacturing Scale, 2022
  • Figure 05: Global Nanoparticle Contract Manufacturing Market Size, by Application, 2022
  • Figure 06: Nanoparticle Contract Manufacturing Market share (%), by Application, 2022
  • Figure 07: Global Nanoparticle Contract Manufacturing Market Size, by End-user, 2022
  • Figure 08: Nanoparticle Contract Manufacturing Market share (%), by End-user, 2022
  • Figure 09: Global Nanoparticle Contract Manufacturing Market, By Region (2022 and 2031)
  • Figure 10: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 11: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn) Share Analysis, by Type of Nanoparticle, 2022 and 2031
  • Figure 12: Global Nanoparticle Contract Manufacturing Market Share Analysis, by Type of Nanoparticles, 2022
  • Figure 13: Global Nanoparticle Contract Manufacturing Market Share Analysis, by Type of Nanoparticles, 2031
  • Figure 14: Global Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Type of Nanoparticles, 2023-2031
  • Figure 15: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn), by Metal Nanoparticles, 2023-2031
  • Figure 16: Global Nanoparticle Contract Manufacturing Market Value Share Analysis, by Metal Nanoparticles, 2022 and 2031
  • Figure 17: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn), by Lipid Nanoparticles, 2023-2031
  • Figure 18: Global Nanoparticle Contract Manufacturing Market Value Share Analysis, by Lipid Nanoparticles, 2022 and 2031
  • Figure 19: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn), by Others, 2023-2031
  • Figure 20: Global Nanoparticle Contract Manufacturing Market Value Share Analysis, by Others, 2022 and 2031
  • Figure 21: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn) Share Analysis, by Manufacturing Scale, 2022 and 2031
  • Figure 22: Global Nanoparticle Contract Manufacturing Market Share Analysis, by Manufacturing Scale, 2022
  • Figure 23: Global Nanoparticle Contract Manufacturing Market Share Analysis, by Manufacturing Scale, 2031
  • Figure 24: Global Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Manufacturing Scale, 2023-2031
  • Figure 25: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn), by Commercial, 2023-2031
  • Figure 26: Global Nanoparticle Contract Manufacturing Market Value Share Analysis, by Commercial, 2022 and 2031
  • Figure 27: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn), by Clinical, 2023-2031
  • Figure 28: Global Nanoparticle Contract Manufacturing Market Value Share Analysis, by Clinical, 2022 and 2031
  • Figure 29: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn), by Pre-clinical, 2023-2031
  • Figure 30: Global Nanoparticle Contract Manufacturing Market Value Share Analysis, by Pre-clinical, 2022 and 2031
  • Figure 31: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031
  • Figure 32: Global Nanoparticle Contract Manufacturing Market Share Analysis, by Application, 2022
  • Figure 33: Global Nanoparticle Contract Manufacturing Market Share Analysis, by Application, 2031
  • Figure 34: Global Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 35: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn), by Therapeutics, 2023-2031
  • Figure 36: Global Nanoparticle Contract Manufacturing Market Value Share Analysis, by Therapeutics, 2022 and 2031
  • Figure 37: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn), by Diagnostics, 2023-2031
  • Figure 38: Global Nanoparticle Contract Manufacturing Market Value Share Analysis, by Diagnostics, 2022 and 2031
  • Figure 39: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn), by Vaccines, 2023-2031
  • Figure 40: Global Nanoparticle Contract Manufacturing Market Value Share Analysis, by Vaccines, 2022 and 2031
  • Figure 41: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
  • Figure 42: Global Nanoparticle Contract Manufacturing Market Share Analysis, by End-user, 2022
  • Figure 43: Global Nanoparticle Contract Manufacturing Market Share Analysis, by End-user, 2031
  • Figure 44: Global Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 45: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn), by Pharmaceutical Companies, 2023-2031
  • Figure 46: Global Nanoparticle Contract Manufacturing Market Value Share Analysis, by Pharmaceutical Companies, 2022 and 2031
  • Figure 47: Global Nanoparticle Contract Manufacturing Market Value (US$ Mn), by Biotechnology Companies, 2023-2031
  • Figure 48: Global Nanoparticle Contract Manufacturing Market Value Share Analysis, by Biotechnology Companies, 2022 and 2031
  • Figure 49: Global Nanoparticle Contract Manufacturing Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 50: Global Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 51: North America Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 52: North America Nanoparticle Contract Manufacturing Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 53: North America Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 54: North America Nanoparticle Contract Manufacturing Market Value Share Analysis, by Type of Nanoparticles, 2022 and 2031
  • Figure 55: North America Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Type of Nanoparticles, 2023-2031
  • Figure 56: North America Nanoparticle Contract Manufacturing Market Value Share Analysis, by Manufacturing Scale, 2022 and 2031
  • Figure 57: North America Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Manufacturing Scale, 2023-2031
  • Figure 58: North America Nanoparticle Contract Manufacturing Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 59: North America Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 60: North America Nanoparticle Contract Manufacturing Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 61: North America Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 62: Europe Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 63: Europe Nanoparticle Contract Manufacturing Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 64: Europe Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 65: Europe Nanoparticle Contract Manufacturing Market Value Share Analysis, by Type of Nanoparticles, 2022 and 2031
  • Figure 66: Europe Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Type of Nanoparticles, 2023-2031
  • Figure 67: Europe Nanoparticle Contract Manufacturing Market Value Share Analysis, by Manufacturing Scale, 2022 and 2031
  • Figure 68: Europe Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Manufacturing Scale, 2023-2031
  • Figure 69: Europe Nanoparticle Contract Manufacturing Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 70: Europe Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 71: Europe Nanoparticle Contract Manufacturing Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 72: Europe Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 73: Asia Pacific Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 74: Asia Pacific Nanoparticle Contract Manufacturing Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 75: Asia Pacific Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 76: Asia Pacific Nanoparticle Contract Manufacturing Market Value Share Analysis, by Type of Nanoparticles, 2022 and 2031
  • Figure 77: Asia Pacific Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Type of Nanoparticles, 2023-2031
  • Figure 78: Asia Pacific Nanoparticle Contract Manufacturing Market Value Share Analysis, by Manufacturing Scale, 2022 and 2031
  • Figure 79: Asia Pacific Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Manufacturing Scale, 2023-2031
  • Figure 80: Asia Pacific Nanoparticle Contract Manufacturing Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 81: Asia Pacific Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 82: Asia Pacific Nanoparticle Contract Manufacturing Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 83: Asia Pacific Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 84: Latin America Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 85: Latin America Nanoparticle Contract Manufacturing Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 86: Latin America Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 87: Latin America Nanoparticle Contract Manufacturing Market Value Share Analysis, by Type of Nanoparticles, 2022 and 2031
  • Figure 88: Latin America Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Type of Nanoparticles, 2023-2031
  • Figure 89: Latin America Nanoparticle Contract Manufacturing Market Value Share Analysis, by Manufacturing Scale, 2022 and 2031
  • Figure 90: Latin America Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Manufacturing Scale, 2023-2031
  • Figure 91: Latin America Nanoparticle Contract Manufacturing Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 92: Latin America Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 93: Latin America Nanoparticle Contract Manufacturing Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 94: Latin America Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 95: Middle East & Africa Nanoparticle Contract Manufacturing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 96: Middle East & Africa Nanoparticle Contract Manufacturing Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 97: Middle East & Africa Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 98: Middle East & Africa Nanoparticle Contract Manufacturing Market Value Share Analysis, by Type of Nanoparticles, 2022 and 2031
  • Figure 99: Middle East & Africa Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Type of Nanoparticles, 2023-2031
  • Figure 100: Middle East & Africa Nanoparticle Contract Manufacturing Market Value Share Analysis, by Manufacturing Scale, 2022 and 2031
  • Figure 101: Middle East & Africa Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Manufacturing Scale, 2023-2031
  • Figure 102: Middle East & Africa Nanoparticle Contract Manufacturing Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 103: Middle East & Africa Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 104: Middle East & Africa Nanoparticle Contract Manufacturing Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 105: Middle East & Africa Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by End-user, 2023-2031
目次
Product Code: TMRGL85027

Nanoparticle Contract Manufacturing Market - Scope of Report

TMR's report on the global nanoparticle contract manufacturing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global nanoparticle contract manufacturing market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global nanoparticle contract manufacturing market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the nanoparticle contract manufacturing market.

Market Snapshot
Market Value in 2023US$ 2.2 Bn
Market Value in 2031US$ 4.3 Bn
CAGR7.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global nanoparticle contract manufacturing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global nanoparticle contract manufacturing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global nanoparticle contract manufacturing market.

The report delves into the competitive landscape of the global nanoparticle contract manufacturing market. Key players operating in the global nanoparticle contract manufacturing market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global nanoparticle contract manufacturing market profiled in this report.

Key Questions Answered in Global nanoparticle contract manufacturing Market Report:

  • What is the sales/revenue generated by nanoparticle contract manufacturing across all regions during the forecast period?
  • What are the opportunities in the global nanoparticle contract manufacturing market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Nanoparticle Contract Manufacturing Market - Research Objectives and Research Approach

The comprehensive report on the global nanoparticle contract manufacturing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global nanoparticle contract manufacturing market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global nanoparticle contract manufacturing market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Nanoparticle Contract Manufacturing Market

4. Market Overview

  • 4.1. Overview
  • 4.2. Market Dynamics
    • 4.2.1. Drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunities
  • 4.3. Global Nanoparticle Contract Manufacturing Market Value Analysis and Forecast, 2023-2031

5. Key Insights

  • 5.1. Key Industry Events
  • 5.2. Technological Advancements
  • 5.3. COVID-19 Pandemic Impact on Industry (Value Chain and Short/Mid/Long Term Impact)

6. Global Nanoparticle Contract Manufacturing Market Analysis, by Type of Nanoparticles

  • 6.1. Introduction
  • 6.2. Global Nanoparticle Contract Manufacturing Market Share Analysis, by Type of Nanoparticles
  • 6.3. Global Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Type of Nanoparticles
  • 6.4. Global Nanoparticle Contract Manufacturing Market Analysis, by Type of Nanoparticles
  • 6.5. Global Nanoparticle Contract Manufacturing Market Forecast, by Type of Nanoparticles
    • 6.5.1. Metal Nanoparticles
    • 6.5.2. Lipid Nanoparticles
    • 6.5.3. Others

7. Global Nanoparticle Contract Manufacturing Market Analysis, by Manufacturing Scale

  • 7.1. Introduction
  • 7.2. Global Nanoparticle Contract Manufacturing Market Share Analysis, by Manufacturing Scale
  • 7.3. Global Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Manufacturing Scale
  • 7.4. Global Nanoparticle Contract Manufacturing Market Analysis, by Manufacturing Scale
  • 7.5. Global Nanoparticle Contract Manufacturing Market Forecast, by Manufacturing Scale
    • 7.5.1. Commercial
    • 7.5.2. Clinical
    • 7.5.3. Pre-clinical

8. Global Nanoparticle Contract Manufacturing Market Analysis, by Application

  • 8.1. Introduction
  • 8.2. Global Nanoparticle Contract Manufacturing Market Share Analysis, by Application
  • 8.3. Global Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Application
  • 8.4. Global Nanoparticle Contract Manufacturing Market Analysis, by Application
  • 8.5. Global Nanoparticle Contract Manufacturing Market Forecast, by Application
    • 8.5.1. Therapeutics
    • 8.5.2. Diagnostics
    • 8.5.3. Vaccines

9. Global Nanoparticle Contract Manufacturing Market Analysis, by End-user

  • 9.1. Introduction
  • 9.2. Global Nanoparticle Contract Manufacturing Market Share Analysis, by End-user
  • 9.3. Global Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by End-user
  • 9.4. Global Nanoparticle Contract Manufacturing Market Analysis, by End-user
  • 9.5. Global Nanoparticle Contract Manufacturing Market Forecast, by End-user
    • 9.5.1. Pharmaceutical Companies
    • 9.5.2. Biotechnology Companies

10. Global Nanoparticle Contract Manufacturing Market Analysis, by Region

  • 10.1. Introduction
  • 10.2. Global Nanoparticle Contract Manufacturing Market Share Analysis, by Region
  • 10.3. Global Nanoparticle Contract Manufacturing Market Attractiveness Analysis, by Region
  • 10.4. Global Nanoparticle Contract Manufacturing Market Forecast, by Region
    • 10.4.1. North America
    • 10.4.2. Europe
    • 10.4.3. Asia Pacific
    • 10.4.4. Latin America
    • 10.4.5. Middle East & Africa

11. North America Nanoparticle Contract Manufacturing Market Analysis

  • 11.1. Key Insights: North America Nanoparticle Contract Manufacturing Market
  • 11.2. North America Nanoparticle Contract Manufacturing Market Overview
  • 11.3. North America Nanoparticle Contract Manufacturing Market Forecast, by Country
    • 11.3.1. U.S.
    • 11.3.2. Canada
  • 11.4. North America Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis, by Type of Nanoparticles
  • 11.5. North America Nanoparticle Contract Manufacturing Market Forecast, by Type of Nanoparticles
    • 11.5.1. Metal Nanoparticles
    • 11.5.2. Lipid Nanoparticles
    • 11.5.3. Others
  • 11.6. North America Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis, by Manufacturing Scale
  • 11.7. North America Nanoparticle Contract Manufacturing Market Forecast, by Manufacturing Scale
    • 11.7.1. Commercial
    • 11.7.2. Clinical
    • 11.7.3. Pre-clinical
  • 11.8. North America Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis, by Application
  • 11.9. North America Nanoparticle Contract Manufacturing Market Forecast, by Application
    • 11.9.1. Therapeutics
    • 11.9.2. Diagnostics
    • 11.9.3. Vaccines
  • 11.10. North America Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis, by End-user
  • 11.11. North America Nanoparticle Contract Manufacturing Market Forecast, by End-user
    • 11.11.1. Pharmaceutical Companies
    • 11.11.2. Biotechnology Companies

12. Europe Nanoparticle Contract Manufacturing Market Analysis

  • 12.1. Key Insights: Europe Nanoparticle Contract Manufacturing Market
  • 12.2. Europe Nanoparticle Contract Manufacturing Market Overview
  • 12.3. Europe Nanoparticle Contract Manufacturing Market Forecast, by Country
    • 12.3.1. Germany
    • 12.3.2. U.K.
    • 12.3.3. France
    • 12.3.4. Italy
    • 12.3.5. Spain
    • 12.3.6. Rest of Europe
  • 12.4. Europe Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis, by Type of Nanoparticles
  • 12.5. Europe Nanoparticle Contract Manufacturing Market Forecast, by Type of Nanoparticles
    • 12.5.1. Metal Nanoparticles
    • 12.5.2. Lipid Nanoparticles
    • 12.5.3. Others
  • 12.6. Europe Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis, by Manufacturing Scale
  • 12.7. Europe Nanoparticle Contract Manufacturing Market Forecast, by Manufacturing Scale
    • 12.7.1. Commercial
    • 12.7.2. Clinical
    • 12.7.3. Pre-clinical
  • 12.8. Europe Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis, by Application
  • 12.9. Europe Nanoparticle Contract Manufacturing Market Forecast, by Application
    • 12.9.1. Therapeutics
    • 12.9.2. Diagnostics
    • 12.9.3. Vaccines
  • 12.10. Europe Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis, by End-user
  • 12.11. Europe Nanoparticle Contract Manufacturing Market Forecast, by End-user
    • 12.11.1. Pharmaceutical Companies
    • 12.11.2. Biotechnology Companies

13. Asia Pacific Nanoparticle Contract Manufacturing Market Analysis

  • 13.1. Key Insights: Asia Pacific Nanoparticle Contract Manufacturing Market
  • 13.2. Asia Pacific Nanoparticle Contract Manufacturing Market Overview
  • 13.3. Asia Pacific Nanoparticle Contract Manufacturing Market Forecast, by Country
    • 13.3.1. China
    • 13.3.2. Japan
    • 13.3.3. India
    • 13.3.4. Australia & New Zealand
    • 13.3.5. Rest of Asia Pacific
  • 13.4. Asia Pacific Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis,
    • 13.4.1. by Type of Nanoparticles
  • 13.5. Asia Pacific Nanoparticle Contract Manufacturing Market Forecast, by Type of Nanoparticles
    • 13.5.1. Metal Nanoparticles
    • 13.5.2. Lipid Nanoparticles
    • 13.5.3. Others
  • 13.6. Asia Pacific Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis, by Manufacturing Scale
  • 13.7. Asia Pacific Nanoparticle Contract Manufacturing Market Forecast, by Manufacturing Scale
    • 13.7.1. Commercial
    • 13.7.2. Clinical
    • 13.7.3. Pre-clinical
  • 13.8. Asia Pacific Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis, by Application
  • 13.9. Asia Pacific Nanoparticle Contract Manufacturing Market Forecast, by Application
    • 13.9.1. Therapeutics
    • 13.9.2. Diagnostics
    • 13.9.3. Vaccines
  • 13.10. Asia Pacific Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis, by End-user
  • 13.11. Asia Pacific Nanoparticle Contract Manufacturing Market Forecast, by End-user
    • 13.11.1. Pharmaceutical Companies
    • 13.11.2. Biotechnology Companies

14. Latin America Nanoparticle Contract Manufacturing Market Analysis

  • 14.1. Key Insights: Latin America Nanoparticle Contract Manufacturing Market
  • 14.2. Latin America Nanoparticle Contract Manufacturing Market Overview
  • 14.3. Latin America Nanoparticle Contract Manufacturing Market Forecast, by Country
    • 14.3.1. Brazil
    • 14.3.2. Mexico
    • 14.3.3. Rest of Latin America
  • 14.4. Latin America Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis, by Type of Nanoparticles
  • 14.5. Latin America Nanoparticle Contract Manufacturing Market Forecast, by Type of Nanoparticles
    • 14.5.1. Metal Nanoparticles
    • 14.5.2. Lipid Nanoparticles
    • 14.5.3. Others
  • 14.6. Latin America Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis, by Manufacturing Scale
  • 14.7. Latin America Nanoparticle Contract Manufacturing Market Forecast, by Manufacturing Scale
    • 14.7.1. Commercial
    • 14.7.2. Clinical
    • 14.7.3. Pre-clinical
  • 14.8. Latin America Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis,by Application
  • 14.9. Latin America Nanoparticle Contract Manufacturing Market Forecast, by Application
    • 14.9.1. Therapeutics
    • 14.9.2. Diagnostics
    • 14.9.3. Vaccines
  • 14.10. Latin America Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis, by End-user
  • 14.11. Latin America Nanoparticle Contract Manufacturing Market Forecast, by End-user
    • 14.11.1. Pharmaceutical Companies
    • 14.11.2. Biotechnology Companies

15. Middle East & Africa Nanoparticle Contract Manufacturing Market Analysis

  • 15.1. Key Insights: Middle East & Africa Nanoparticle Contract Manufacturing Market
  • 15.2. Middle East & Africa Nanoparticle Contract Manufacturing Market Overview
  • 15.3. Middle East & Africa Nanoparticle Contract Manufacturing Market Forecast, by Country
    • 15.3.1. GCC Countries
    • 15.3.2. South Africa
    • 15.3.3. Rest of Middle East & Africa
  • 15.4. Middle East & Africa Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis, by Type of Nanoparticles
  • 15.5. Middle East & Africa Nanoparticle Contract Manufacturing Market Forecast, by Type of Nanoparticles
    • 15.5.1. Metal Nanoparticles
    • 15.5.2. Lipid Nanoparticles
    • 15.5.3. Others
  • 15.6. Middle East & Africa Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis, by Manufacturing Scale
  • 15.7. Middle East & Africa Nanoparticle Contract Manufacturing Market Forecast, by Manufacturing Scale
    • 15.7.1. Commercial
    • 15.7.2. Clinical
    • 15.7.3. Pre-clinical
  • 15.8. Middle East & Africa Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis, by Application
  • 15.9. Middle East & Africa Nanoparticle Contract Manufacturing Market Forecast, by Application
    • 15.9.1. Therapeutics
    • 15.9.2. Diagnostics
    • 15.9.3. Vaccines
  • 15.10. Middle East & Africa Nanoparticle Contract Manufacturing Market Share & Attractiveness Analysis, by End-user
  • 15.11. Middle East & Africa Nanoparticle Contract Manufacturing Market Forecast, by End-user
    • 15.11.1. Pharmaceutical Companies
    • 15.11.2. Biotechnology Companies

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 16.2. Market Share Analysis, by Company (2022)
  • 16.3. Company Profiles
    • 16.3.1. AstraZeneca
      • 16.3.1.1. Company Overview
      • 16.3.1.2. Financial Overview
      • 16.3.1.3. Product Portfolio
      • 16.3.1.4. Business Strategies
      • 16.3.1.5. Recent Developments
    • 16.3.2. Evonik Industries AG
      • 16.3.2.1. Company Overview
      • 16.3.2.2. Financial Overview
      • 16.3.2.3. Product Portfolio
      • 16.3.2.4. Business Strategies
      • 16.3.2.5. Recent Developments
    • 16.3.3. Ascendia Pharmaceuticals
      • 16.3.3.1. Company Overview
      • 16.3.3.2. Financial Overview
      • 16.3.3.3. Product Portfolio
      • 16.3.3.4. Business Strategies
      • 16.3.3.5. Recent Developments
    • 16.3.4. Axolabs (LGC Limited)
      • 16.3.4.1. Company Overview
      • 16.3.4.2. Financial Overview
      • 16.3.4.3. Product Portfolio
      • 16.3.4.4. Business Strategies
      • 16.3.4.5. Recent Developments
    • 16.3.5. AVANSA Technology & Services
      • 16.3.5.1. Company Overview
      • 16.3.5.2. Financial Overview
      • 16.3.5.3. Product Portfolio
      • 16.3.5.4. Business Strategies
      • 16.3.5.5. Recent Developments
    • 16.3.6. Ardena Holding NV.
      • 16.3.6.1. Company Overview
      • 16.3.6.2. Financial Overview
      • 16.3.6.3. Product Portfolio
      • 16.3.6.4. Business Strategies
      • 16.3.6.5. Recent Developments
    • 16.3.7. Cytodiagnostics, Inc.
      • 16.3.7.1. Company Overview
      • 16.3.7.2. Financial Overview
      • 16.3.7.3. Product Portfolio
      • 16.3.7.4. Business Strategies
      • 16.3.7.5. Recent Developments
    • 16.3.8. American Elements
      • 16.3.8.1. Company Overview
      • 16.3.8.2. Financial Overview
      • 16.3.8.3. Product Portfolio
      • 16.3.8.4. Business Strategies
      • 16.3.8.5. Recent Developments
    • 16.3.9. Encapsula NanoSciences LLC
      • 16.3.9.1. Company Overview
      • 16.3.9.2. Financial Overview
      • 16.3.9.3. Product Portfolio
      • 16.3.9.4. Business Strategies
      • 16.3.9.5. Recent Developments
    • 16.3.10. Fortis Life Sciences
      • 16.3.10.1. Company Overview
      • 16.3.10.2. Financial Overview
      • 16.3.10.3. Product Portfolio
      • 16.3.10.4. Business Strategies
      • 16.3.10.5. Recent Developments
    • 16.3.11. Hongwu International Group Ltd.
      • 16.3.11.1. Company Overview
      • 16.3.11.2. Financial Overview
      • 16.3.11.3. Product Portfolio
      • 16.3.11.4. Business Strategies
      • 16.3.11.5. Recent Developments
    • 16.3.12. MyBiotech
      • 16.3.12.1. Company Overview
      • 16.3.12.2. Financial Overview
      • 16.3.12.3. Product Portfolio
      • 16.3.12.4. Business Strategies
      • 16.3.12.5. Recent Developments
    • 16.3.13. Nanochemazone
      • 16.3.13.1. Company Overview
      • 16.3.13.2. Financial Overview
      • 16.3.13.3. Product Portfolio
      • 16.3.13.4. Business Strategies
      • 16.3.13.5. Recent Developments